Skip to main content
. 2019 Dec 19;13:4331–4340. doi: 10.2147/DDDT.S225613

Figure 2.

Figure 2

Routine blood marker changes during different times. TP (A), ALB (B), globulin (C), platelet (D), WB (E) and MCV (F) before treatment and 1-year posttreatment and 3-year posttreatment with umbilical cord mesenchymal stem cells (UC-MSCs) plus disease-modifying anti-rheumatic drugs (DMARDs). Pre-treatment versus after the first or second treatment; * represents P < 0.05, ns represents no significance difference (n = 64).